Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

CDK inhibitors: cell cycle regulators and beyond.

Besson A, Dowdy SF, Roberts JM.

Dev Cell. 2008 Feb;14(2):159-69. doi: 10.1016/j.devcel.2008.01.013. Review.

2.

Identification of Xenopus cyclin-dependent kinase inhibitors, p16Xic2 and p17Xic3.

Daniels M, Dhokia V, Richard-Parpaillon L, Ohnuma S.

Gene. 2004 Nov 10;342(1):41-7.

PMID:
15527964
3.

Functions, regulation and cellular localization of plant cyclin-dependent kinase inhibitors.

Wang H, Zhou Y, Bird DA, Fowke LC.

J Microsc. 2008 Aug;231(2):234-46. doi: 10.1111/j.1365-2818.2008.02039.x. Review.

4.

Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development.

Nakayama K, Nakayama K.

Bioessays. 1998 Dec;20(12):1020-9. Review.

PMID:
10048302
5.

Activation of an alfalfa cyclin-dependent kinase inhibitor by calmodulin-like domain protein kinase.

Pettkó-Szandtner A, Mészáros T, Horváth GV, Bakó L, Csordás-Tóth E, Blastyák A, Zhiponova M, Miskolczi P, Dudits D.

Plant J. 2006 Apr;46(1):111-23.

6.

Cell-cycle molecules in mesothelioma: an overview.

Spugnini EP, Campioni M, D'Avino A, Caruso G, Citro G, Baldi A.

J Exp Clin Cancer Res. 2007 Dec;26(4):443-9. Review.

PMID:
18365537
7.

Expression levels of p18INK4C modify the cellular efficacy of cyclin-dependent kinase inhibitors via regulation of Mcl-1 expression in tumor cell lines.

Eguchi T, Itadani H, Shimomura T, Kawanishi N, Hirai H, Kotani H.

Mol Cancer Ther. 2009 Jun;8(6):1460-72. doi: 10.1158/1535-7163.MCT-08-1159. Epub 2009 Jun 9.

8.

Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors.

Starostina NG, Kipreos ET.

Trends Cell Biol. 2012 Jan;22(1):33-41. doi: 10.1016/j.tcb.2011.10.004. Epub 2011 Dec 9. Review.

10.

RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.

Zhang S, Tang Q, Xu F, Xue Y, Zhen Z, Deng Y, Liu M, Chen J, Liu S, Qiu M, Liao Z, Li Z, Luo D, Shi F, Zheng Y, Bi F.

Mol Cancer Res. 2009 Apr;7(4):570-80. doi: 10.1158/1541-7786.MCR-08-0248.

11.

Expression of Ol-KIP, a cyclin-dependent kinase inhibitor, in embryonic and adult medaka (Oryzias latipes) central nervous system.

Nguyên V, Candal Suárez EM, Sharif A, Joly JS, Bourrat F.

Dev Dyn. 2001 Nov;222(3):439-49.

12.

Cyclin-dependent kinase inhibitors in yeast, animals, and plants: a functional comparison.

De Clercq A, Inzé D.

Crit Rev Biochem Mol Biol. 2006 Sep-Oct;41(5):293-313. Review.

PMID:
16911957
13.

Molecular control of brain size: regulators of neural stem cell life, death and beyond.

Joseph B, Hermanson O.

Exp Cell Res. 2010 May 1;316(8):1415-21. doi: 10.1016/j.yexcr.2010.03.012. Epub 2010 Mar 19. Review.

PMID:
20307536
14.

Post-translational regulation of the tumor suppressor p27(KIP1).

Vervoorts J, Lüscher B.

Cell Mol Life Sci. 2008 Oct;65(20):3255-64. doi: 10.1007/s00018-008-8296-7. Review.

PMID:
18636226
15.

INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions.

Cánepa ET, Scassa ME, Ceruti JM, Marazita MC, Carcagno AL, Sirkin PF, Ogara MF.

IUBMB Life. 2007 Jul;59(7):419-26. Review.

16.

Temporal-spatial expressions of p27kip1 and its phosphorylation on Serine-10 after acute spinal cord injury in adult rat: Implications for post-traumatic glial proliferation.

Shen A, Liu Y, Zhao J, Qin J, Shi S, Chen M, Gao S, Xiao F, Lu Q, Cheng C.

Neurochem Int. 2008 May;52(6):1266-75. doi: 10.1016/j.neuint.2008.01.011. Epub 2008 Jan 31.

PMID:
18319192
17.

RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt.

Thaler S, Hähnel PS, Schad A, Dammann R, Schuler M.

Cancer Res. 2009 Mar 1;69(5):1748-57. doi: 10.1158/0008-5472.CAN-08-1377. Epub 2009 Feb 17.

18.

Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.

Lee SJ, Cho YH, Park K, Kim EJ, Jung KH, Park SS, Kim WJ, Moon SK.

Biochem Pharmacol. 2008 Jun 15;75(12):2289-300. doi: 10.1016/j.bcp.2008.03.022. Epub 2008 Apr 8.

PMID:
18468578
19.

A potential role of connexin 43 in epidermal growth factor-induced proliferation of mouse embryonic stem cells: involvement of Ca2+/PKC, p44/42 and p38 MAPKs pathways.

Park JH, Lee MY, Heo JS, Han HJ.

Cell Prolif. 2008 Oct;41(5):786-802. doi: 10.1111/j.1365-2184.2008.00552.x.

PMID:
18823499
20.

Functional characterization of the tomato cyclin-dependent kinase inhibitor SlKRP1 domains involved in protein-protein interactions.

Nafati M, Frangne N, Hernould M, Chevalier C, Gévaudant F.

New Phytol. 2010 Oct;188(1):136-49. doi: 10.1111/j.1469-8137.2010.03364.x. Epub 2010 Jul 7.

Supplemental Content

Support Center